• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Modella Woollens Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
503772
INE380D01012
-5.8241758
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
4.7
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

kalind ltd
Strides Pharma Science consolidated net profit rises 54.45% in the March 2026 quarter
May 18,2026
Net profit of Strides Pharma Science rose 54.45% to Rs 126.94 crore in the quarter ended March 2026 as against Rs 82.19 crore during the previous quarter ended March 2025. Sales rose 11.18% to Rs 1323.47 crore in the quarter ended March 2026 as against Rs 1190.39 crore during the previous quarter ended March 2025.

For the full year,net profit declined 84.52% to Rs 556.19 crore in the year ended March 2026 as against Rs 3593.46 crore during the previous year ended March 2025. Sales rose 6.43% to Rs 4858.68 crore in the year ended March 2026 as against Rs 4565.34 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1323.471190.39 11 4858.684565.34 6
OPM %18.1118.30 -19.0417.58 -
PBDT207.71182.66 14 897.93614.52 46
PBT154.46133.80 15 695.53422.26 65
NP126.9482.19 54 556.193593.46 -85